Monday 14 January 2019

Fire Fighting Chemicals Market Growth Factors, Trends and Forecast Report to 2025:Grand View Research, Inc.


San Francisco, 14 January, Fire Fighting Chemicals Market Analysis By Type (Dry Chemicals, Wet Chemicals, Dry Powder, Foam-based), By Chemicals (Monoammonium Phosphate, Halon, Carbon Dioxide, Potassium Bicarbonate, Potassium Citrate, Sodium Chloride), And Segment Forecasts, 2018 - 2025
The global firefighting chemicals market is expected to reach USD 2.94 billion by 2025, according to a new report by Grand View Research, Inc. Increasing safety concerns has been a major factor driving market growth. Employment of fire fighting chemicals services has increased owing to increasing number of favorable fire safety regulations.
Fire fighting chemicals are primarily utilized in fire fighting equipment such as automatic sprinkler systems, fixed and portable fire extinguishers, fire dampers, inert gas systems, and fire retardant bulkhead. These fire suppression chemicals are then sprayed by means of fire extinguisher over the combustion zone, in order to alleviate its temperature and thus eventually extinguish the fire.
Potassium bicarbonate is projected to be the fastest growing segment in the chemicals category over the forecast period with an estimated CAGR of 5.1% from 2017 to 2025. Potassium bicarbonate is the only dry chemical certified by National Fire Protection Agency (NFPA) U.S. for use in Aircraft Rescue and Fire Fighting (ARFF). Potassium bicarbonate is also the most preferable dry chemical for use in oil spill incidences on onshore & offshore drilling sites. It is a salty, colorless and odorless chemical. These factors are projected to boost the potassium bicarbonate segment growth over the forecast period.
Server rooms are utilized to serve as a data center. These server rooms are kept air conditioned in order to drive out the heat generated by the constant rapid activity of data transferring. However, if in case the air conditioners malfunction it might lead to heating up of the room and also cause a fire hazard. Owing to this factor, fire dampers are utilized to stop the oxygen supply to the room in case of fire occurrence. On account of this factor, fire dampers application segment is expected to show a moderate to high growth rate over the forecast period. In terms of volume, the fire dampers segment had a market share of 20.3% in 2016.
Access Full Research Report On Fire Fighting Chemicals Market  Analysis:

Further key findings from the report suggest:
·         The global fire fighting chemicals demand in terms of revenue was USD 2.10 billion in 2016 and is expected to grow at a CAGR of 3.9% from 2017 to 2025
·         Dry chemicals emerged as the largest type segment in 2016 and is estimated to generate revenue over USD 1.09 billion by 2025
·         Fire retardant bulkhead is anticipated to be the fastest growing application segment over the next eight years and in terms of revenue is estimated to grow at a CAGR of 4.3%
·         The Asia Pacific region in terms of revenue is anticipated to witness high growth at a CAGR of 6.2% by 2025. Increasing governmental initiative for fire safety and favorable regulations are expected to propel the regional market growth
·         Key players of the industry include Solvay S.A., EuroChem Group AG, Linde AG, Air Products & Chemicals, Inc., and Praxair, Inc. These major players have forward integrated their operations in order to gain competitive advantage in the market
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the global fire fighting chemicals market on the basis of type, chemicals, application, and region:
Type Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)
·         Dry chemicals
·         Wet chemicals
·         Dry powder
·         Foam-based
Chemicals Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)
·         Monoammonium phosphate
·         Halon
·         Carbon dioxide
·         Potassium bicarbonate
·         Potassium citrate
·         Sodium chloride
·         Others
Application Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)
·         Portable fire extinguishers
·         Automatic fire sprinklers
·         Fire retardant bulkhead
·         Fire dampers
·         Others
Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    UK
o    Russia
o    Germany
o    France
·         Asia Pacific
o    China
o    India
o    South Korea
·         Central & South America
o    Brazil
o    Argentina
·         Middle East & Africa
o    Saudi Arabia

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/




Behavioral Rehabilitation Market Growth Factors, Trends and Forecast Report to 2025:Grand View Research, Inc.


San Francisco, 14 January, Behavioral Rehabilitation Market Size and Forecast By Application (Anxiety, Mood, Substance Abuse, Personality, Attention Deficit Disorders), By Healthcare Settings (Inpatient, Residential, and Outpatient), And Trend Analysis From 2018 - 2025

The global behavioral rehabilitation market is expected to reach USD 313.9 billion by 2025, according to a new report by Grand View Research, Inc. Behavioral rehabilitation market is anticipated to experience growth during the forecast period due to presence of favorable government initiatives, rising number of service providers, and growing awareness among patients. Furthermore, increasing incidence of depression and substance abuse cases services provided by various hospitals for behavioral disorders is anticipated to boost the market growth.
The market is currently in a growth phase with rising number of participants as the demand-supply gap of these services is high in most of the regions. The dynamics is driving it toward being a consolidated market with significant number of mergers and acquisition observed in past few years. Major institutes are focused on regional expansions to provide outpatient services, which are preferred over other healthcare settings owing to cost benefits. Some of the major mergers and acquisitions have been observed in the U.S., including acquisition of adult service division of Cambian group PLC by Universal Health Services, Inc. and announcement of Acadia Healthcare Company, Inc. acquiring the U.K.-based Priory Group.
Access Full Research Report On Behavioral Rehabilitation Market  Analysis:

Further Key Findings From the Study Suggest:
·         Higher prevalence of behavioral diseases associated with emotions & stress and rising awareness about the treatment options are factors driving the growth.
·         Social acceptance of substance abuse patients and rising government initiatives directed toward countering the same is expected to drive this segment with the highest CAGR during the forecast period
·         Outpatient segment dominated in 2015 as it is mostly preferred over the other healthcare settings
·         Affordability and high patient convenience are factors expected to fuel outpatient segment’s growth with the highest CAGR during the forecast period
·         North America dominated 2015 owing to factors such as availability of a large number of institutes and higher awareness levels
·         Europe is expected to show the fastest growth rate during the forecast period with growing adoption of advanced technology in the behavioral healthcare industry, including record keeping software
·         Few of the major players participating in the market are Acadia Healthcare; Magellan Health; Universal Health Services, Inc.; CRC Health; Psychiatric Solutions, Inc.; Behavioral Health Group; Springstone, Inc.; Haven Behavioral Healthcare, Inc.; and American Addiction Centers, Inc.
Browse More Reports Of This Category By Grand View Research At:  https://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the behavioral rehabilitation market on the basis of application, healthcare settings, and region:
Behavioral Rehabilitation Application Outlook (Revenue, USD Billion, 2014 - 2025)
·         Anxiety Disorders
·         Mood Disorders
·         Substance Abuse Disorders
·         Personality Disorders
·         Attention Deficit Disorders
Behavioral Rehabilitation Healthcare Settings Outlook (Revenue, USD Billion 2014 - 2025)
·         Inpatient
·         Residential
·         Outpatient
Behavioral Rehabilitation Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa


Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/




Hemoglobinopathies Market Size To Reach USD 8.82 Billion By 2022:Grand View Research, Inc.


San Francisco, 14 January, Hemoglobinopathies Market Size & Forecast By Type (Alpha Thalassemia, Beta thalassemia, Sickle Cell Disease, Hb Variants Diseases), By Therapy (Blood Transfusion, Iron Chelation Therapy, Bone Marrow Transplant, Hydroxyurea), By Diagnosis (Blood Testing, Genetic Testing, Prenatal Genetic Testing, Pre-implantation Genetic Diagnosis, Hemoglobin Electrophoresis) And Trend Analysis From 2012 To 2022

Global hemoglobinopathies market is expected to reach over USD 8.82 billion by 2022 according to a new report by Grand View Research Inc. Rising prevalence of hemoglobin disorders such as sickle cell anemia, thalassemia, Hb C, and Hb E is estimated to be the high impact rendering drivers of the market. According to the WHO, hemoglobin disorders are endemic in over 60% of 229 countries affecting over 70% of births. It is also reported that minimum 5% of the world population are carriers of significant variation. 
Prevalence of hemoglobinopathies is high in low-income countries such as Sub Saharan region and South East Asia. 85% of the affected population in the U.S. and Europe has ancestral base in these regions. 
Governments are collaborating with local institutes to undertake awareness programs for curbing the effect of hemoglobinopathies-related mortality rate. For instance, Thalassemia Data Collection Project and Registry and Surveillance System for Hemoglobinopathies (RuSH) projects were started in 2010 by the Centers for Disease Control and Prevention (CDC). 
Low level of hygiene, insufficient healthcare infrastructure, and lesser awareness levels are some key factors attributing to increase in base of target population in low-income regions such as South East Asia, Mediterranean basin, and Africa. 
Access Full Research Report On Hemoglobinopathies Market  Analysis:

Further key findings from the study suggest:
·         The market for Sickle Cell Disease (SCD) was the largest with revenue valued at over USD 2,290.0 million in 2014. Rising prevalence of hemoglobinopathies and presence of strong product pipeline for sickle cell anemia such as HQK-1001 and Luspatercept are growth promoting factors of this market.
·         Genetic testing for diagnosis of sickle cell disorders is expected to witness lucrative growth over the forecast period. It is estimated to grow at a CAGR of around 7.0%. Increasing awareness levels among people coupled with government programs such as the National Sickle Cell Disease Control Program conducted by the WHO in Africa are anticipated to enhance the usage rates for diagnostic tests pertaining to SCD.
·         Hydroxyurea was one of the dominating segments of the SCD therapy market owing to the presence of the FDA-approved drugs such as Droxia and Hydrea by Bristol Myers Squib. SCD. Thalassemia market holds an extensive product portfolio in pipeline and their expected commercialization is anticipated to drive market growth. For instance, The Ellis Lab is developing a gene therapy for SCD in collaboration with Dr. Victor Garcia
·         Blood tests including cell blood count and iron studies are the widely used techniques for diagnosis of thalassemia. On the other hand, pre-implant genetic testing is estimated to grow at lucrative growth rate over 8.5% in the next six years owing to rising base of health conscious population and increasing healthcare expenditure.
·         The market for blood transfusion was the largest with revenues valued at over USD 1,408.0 million in therapeutic segment owing to, high acceptance level of this treatment option and significant success rate. It is estimated that around 85% of infants below five years suffering from thalassemia die due to insufficient blood transfusion.
·         North America dominated the overall hemoglobinopathies market in terms of revenue in 2014 at over USD 1,212.0 million. Growing prevalence of blood disorders, favorable government programs, and high level of awareness among healthcare professionals and patients for hemoglobinopathies-related genetic testing are factors attributing to the major share of this market.
·         Asia Pacific market is expected to witness lucrative growth over the forecast period with a CAGR of over 10% owing to the presence of high unmet clinical needs, improving healthcare infrastructure, and rising economic levels. Moreover, introduction of low-cost diagnostic alternatives will enhance adoption rates for hemoglobinopathies diagnostics market.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the hemoglobinopathies market on the basis of type, diagnostics, and therapeutics:
Global Hemoglobinopathies Therapy Outlook (Revenue, USD Million), 2012 – 2022
·         Thalassemia
o    Alpha thalassemia
o    Beta thalassemia
·         Sickle cell disease
·         Hemoglobin variants diseases
Global Hemoglobinopathies Diagnosis Outlook (Revenue, USD Million), 2012 – 2022
·         Thalassemia
o    Alpha thalassemia
o    Beta thalassemia
·         Sickle cell disease
·         Hemoglobin variants diseases
Hemoglobinopathies Regional Outlook (Revenue, USD Million), 2012 – 2022
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/